Sexual behavior and pregnancy outcome in HIV-infected women

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 5, 1998, Pages 479-487

  Hankins, Catherine ^a,b,d   Tran, Thang ^a   Lapointe, Normand ^c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d Infectious Diseases Unit   (Canada)

Author keywords

AIDS; Contraception; HIV; Pregnancy; Sexual behavior; Therapeutic abortion; Women

Indexed keywords

ZIDOVUDINE;

ADOLESCENT; ADULT; ARTICLE; CONTRACEPTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; VIRUS TRANSMISSION;

EID: 0032529421     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199808150-00010     Document Type: Article

References (28)

1. Clark RA, Kissinger P, Bedime AL, Dunn P, Albertin H. Determination of factors associated with condom use among women infected with human immunodeficiency virus. Int J STD AIDS 1997;8:229-33.
2. Clark RA, Kissinger P, Williams T. Contraceptive and sexually transmitted diseases protection among adult and adolescent women infected with human immunodeficiency virus. Int J STD AIDS 1996;7:439-42.
3. Hankins C, Gendron S, Tran T, Lamping D, Lapointe N. Sexuality in Montreal women living with HIV. AIDS Care 1997;9:261-71.
4. Hankins C, Tran T, Lapointe N. How sexually active are Canadian women living with HIV? AIDS impact [abstract M4C.1.]. Presented at the Biopsychosocial Aspects of HIV Infection. III International Conference, Melbourne, Australia, 1997.
5. De Vincenzi I, Jadand C, Couturier E, et al. Pregnancy and contraception in a French cohort of HIV-infected women. AIDS 1997; 11:333-8.
6. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
7. Health Canada. AIDS in Canada: quarterly surveillance update. Ottawa: Division of HIV/AIDS Surveillance. Bureau of HIV/AIDS and STD, LCDC, HPB, Health Canada, August 1997.
8. Zierler S, Stein M, Schoenbaum E, Solomon L, Schuman P, Moore J. Comparison of women's sexual activity according to HIV serostatus[abstract FF1-192], Proceedings of HIV Infection in Women: Setting a New Agenda, Washington, DC: Philadelphia Sciences Group, 1995.
9. Murphy D, Lynch M, Desmond N, Mulcahy FM. Contraceptive practices in HIV seropositive females in Ireland. Int J STD AIDS 1993;4:107-9.
10. Chung J, Magraw M. A group approach to psychosocial issues faced by HIV-positive women. Hosp Commun Psychiatry 1992; 43:891-4.
11. Meyer-Bahlburg HF, Nostlinger C, Exner TM, et al. Sexual functioning in HIV- and HIV-injected-drug-using women. J Sex Marital Ther 1993;19:56-68.
12. Brown G, Rundell J, Pace J, Zachary R, Kendall S. Psychiatric morbidity in early HIV infection in women: results of a 4 year prospective study. Biopsychosocial Aspects of HIV Infection, First International Conference Final Programme and Abstract Book, 1991:21.
13. Brown G, Rundell J. Prospective study of psychiatric morbidity in HIV-seropositive women without AIDS. Gen Hosp Psychiatry 1990;12:30-5.
14. Canadian Centre on Substance Abuse. Canadian Public Health Association. HIV, AIDS and injection drug use: a national action plan. Ottawa: Health Canada, 1997.
15. Uchtenhagen A. Programme for a medical prescription of narcotics: summary of the synthesis report. Berne: Swiss Federal Office of Public Health, 1997.
16. Fahey JL, Taylor JMG, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990;322:166-72.
17. Schechter MT, Craib KJP, Le TN, et al. Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men. AIDS 1989;3:347-53.
18. Hofmann B, Wang Y, Cumberland WG, Detels R, Bozorgmehri M, Fahey JL. Serum beta-2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis. AIDS 1990;4:207-14.
19. Polk BF, Fox R, Brookmeyer R et al. Predictors of acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987;316:61-6.
20. Moss AR, Bacchetti P. Natural history of HIV infection. AIDS 1989;3:55-61.
21. Heyward WL, Batter VL, Malulu M, et al. Impact of HIV counseling and testing among child-bearing women in Kinshasa, Zaire. AIDS 1993;7:1633-37.
22. Selwyn PA, Carter RJ, Schoenbaum EE. Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA 1989;261:3567-71.
23. Sunderland A, Moroso G, Berthaud M, et al. Influence of HIV infection on pregnancy decisions [abstract 6607]. Presented at the IV International Conference on AIDS, Stockholm, Sweden, 1988.
24. Selwyn PA, Schoenbaum EE, Davenny K, et al. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA 1989;261:1289-94.
25. Gray RH, Wawer MJ, Serwadda D, et al. Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 1998;351:98-103.
26. Levasseur C, Pineault R, Hankins C. Facteurs psychosociaux influençant l'intention des femmes infectées par le VIH d'avoir un enfant: étude de cas. Santé Mentale Québec 1992;17:177-94.
27. Lai KK. Attitudes toward childbearing and changes in sexual and contraceptive practices among HIV-infected women. Cleve Clin J Med 1994;61:132-6.
28. Fogerty LA, Gielen AC, Faden R, Eke A, Cohen A, Armstrong K. Women's reproductive decisions and the role of health care providers [abstract 223.3]. National Conference on Women and HIV: abstracts-on-disk, Northfield, MI: Marathon Multimedia, 1997.